Ozempic and Wegovy Now Available After Prolonged Shortages

The FDA confirms all doses of Novo Nordisk's popular drugs are listed as available, though they remain on the shortage list.

Novo Nordisk's efforts to increase the supply of Ozempic and Wegovy have led to all doses being listed as available in the U.S.
The FDA is evaluating whether the current supply can meet the growing demand for these medications.
Despite being listed as available, Ozempic and Wegovy are not fully removed from the FDA's drug shortage list.
Novo Nordisk has been working closely with the FDA and investing in manufacturing capacity to address shortages.
The availability update could impact compounding pharmacies, which have been making unapproved versions of these drugs.